Selected research
Market Structure
Global Sulforaphane Capsule Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Sulforaphane Capsule market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Sulforaphane Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Sulforaphane Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sulforaphane Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Sulforaphane Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sulforaphane Capsule include YANGO, Avmacol, Bioherba, Carlyle, Cellavent Healthcare, Coyne, Jarrow Formulas, Matakana and MCS Formulas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Sulforaphane Capsule market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sulforaphane Capsule and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sulforaphane Capsule sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sulforaphane Capsule market size, projected growth trends, production technologies, key applications, and end-use industries.
Sulforaphane Capsule Segment by Company
YANGO
Avmacol
Bioherba
Carlyle
Cellavent Healthcare
Coyne
Jarrow Formulas
Matakana
MCS Formulas
Metagenics
SMNutrition
Swanson
Throne
Zein
Sulforaphane Capsule Segment by Type
≤400mg
＞400mg
Sulforaphane Capsule Segment by Application
Offline Sales
Online Sales
Sulforaphane Capsule Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sulforaphane Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sulforaphane Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sulforaphane Capsule.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Sulforaphane Capsule market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sulforaphane Capsule manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sulforaphane Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sulforaphane Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- ≤400mg
- ＞400mg
Applications
- Offline Sales
- Online Sales
Companies covered
- YANGO
- Avmacol
- Bioherba
- Carlyle
- Cellavent Healthcare
- Coyne
- Jarrow Formulas
- Matakana
- MCS Formulas
- Metagenics
- SMNutrition
- Swanson
- Throne
- Zein
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Sulforaphane Capsule Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Sulforaphane Capsule Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Sulforaphane Capsule Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Sulforaphane Capsule Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Sulforaphane Capsule Market Dynamics
- 2.1 Sulforaphane Capsule Industry Trends
- 2.2 Sulforaphane Capsule Industry Drivers
- 2.3 Sulforaphane Capsule Industry Opportunities and Challenges
- 2.4 Sulforaphane Capsule Industry Restraints
3 Sulforaphane Capsule Market by Manufacturers
- 3.1 Global Sulforaphane Capsule Revenue by Manufacturers (2021-2026)
- 3.2 Global Sulforaphane Capsule Sales by Manufacturers (2021-2026)
- 3.3 Global Sulforaphane Capsule Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Sulforaphane Capsule Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sulforaphane Capsule Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Sulforaphane Capsule Manufacturers, Product Type & Application
- 3.7 Global Sulforaphane Capsule Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sulforaphane Capsule Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sulforaphane Capsule Players Market Share by Revenue in 2025
- 3.8.3 2025 Sulforaphane Capsule Tier 1, Tier 2, and Tier 3
4 Sulforaphane Capsule Market by Type
- 4.1 Sulforaphane Capsule Type Introduction
- 4.1.1 ≤400mg
- 4.1.2 ＞400mg
- 4.2 Global Sulforaphane Capsule Sales by Type
- 4.2.1 Global Sulforaphane Capsule Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Sulforaphane Capsule Sales by Type (2021-2032)
- 4.2.3 Global Sulforaphane Capsule Sales Market Share by Type (2021-2032)
- 4.3 Global Sulforaphane Capsule Revenue by Type
- 4.3.1 Global Sulforaphane Capsule Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Sulforaphane Capsule Revenue by Type (2021-2032)
- 4.3.3 Global Sulforaphane Capsule Revenue Market Share by Type (2021-2032)
5 Sulforaphane Capsule Market by Application
- 5.1 Sulforaphane Capsule Application Introduction
- 5.1.1 Offline Sales
- 5.1.2 Online Sales
- 5.2 Global Sulforaphane Capsule Sales by Application
- 5.2.1 Global Sulforaphane Capsule Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Sulforaphane Capsule Sales by Application (2021-2032)
- 5.2.3 Global Sulforaphane Capsule Sales Market Share by Application (2021-2032)
- 5.3 Global Sulforaphane Capsule Revenue by Application
- 5.3.1 Global Sulforaphane Capsule Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Sulforaphane Capsule Revenue by Application (2021-2032)
- 5.3.3 Global Sulforaphane Capsule Revenue Market Share by Application (2021-2032)
6 Global Sulforaphane Capsule Sales by Region
- 6.1 Global Sulforaphane Capsule Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sulforaphane Capsule Sales by Region (2021-2032)
- 6.2.1 Global Sulforaphane Capsule Sales by Region (2021-2026)
- 6.2.2 Global Sulforaphane Capsule Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sulforaphane Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sulforaphane Capsule Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sulforaphane Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sulforaphane Capsule Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sulforaphane Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sulforaphane Capsule Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Sulforaphane Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Sulforaphane Capsule Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Sulforaphane Capsule Revenue by Region
- 7.1 Global Sulforaphane Capsule Revenue by Region
- 7.1.1 Global Sulforaphane Capsule Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Sulforaphane Capsule Revenue by Region (2021-2026)
- 7.1.3 Global Sulforaphane Capsule Revenue by Region (2027-2032)
- 7.1.4 Global Sulforaphane Capsule Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Sulforaphane Capsule Revenue (2021-2032)
- 7.2.2 North America Sulforaphane Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Sulforaphane Capsule Revenue (2021-2032)
- 7.3.2 Europe Sulforaphane Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Sulforaphane Capsule Revenue (2021-2032)
- 7.4.2 Asia-Pacific Sulforaphane Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Sulforaphane Capsule Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Sulforaphane Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 YANGO
- 8.1.1 YANGO Company Information
- 8.1.2 YANGO Business Overview
- 8.1.3 YANGO Sulforaphane Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 YANGO Sulforaphane Capsule Product Portfolio
- 8.1.5 YANGO Recent Developments
- 8.2 Avmacol
- 8.2.1 Avmacol Company Information
- 8.2.2 Avmacol Business Overview
- 8.2.3 Avmacol Sulforaphane Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Avmacol Sulforaphane Capsule Product Portfolio
- 8.2.5 Avmacol Recent Developments
- 8.3 Bioherba
- 8.3.1 Bioherba Company Information
- 8.3.2 Bioherba Business Overview
- 8.3.3 Bioherba Sulforaphane Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Bioherba Sulforaphane Capsule Product Portfolio
- 8.3.5 Bioherba Recent Developments
- 8.4 Carlyle
- 8.4.1 Carlyle Company Information
- 8.4.2 Carlyle Business Overview
- 8.4.3 Carlyle Sulforaphane Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Carlyle Sulforaphane Capsule Product Portfolio
- 8.4.5 Carlyle Recent Developments
- 8.5 Cellavent Healthcare
- 8.5.1 Cellavent Healthcare Company Information
- 8.5.2 Cellavent Healthcare Business Overview
- 8.5.3 Cellavent Healthcare Sulforaphane Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Cellavent Healthcare Sulforaphane Capsule Product Portfolio
- 8.5.5 Cellavent Healthcare Recent Developments
- 8.6 Coyne
- 8.6.1 Coyne Company Information
- 8.6.2 Coyne Business Overview
- 8.6.3 Coyne Sulforaphane Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Coyne Sulforaphane Capsule Product Portfolio
- 8.6.5 Coyne Recent Developments
- 8.7 Jarrow Formulas
- 8.7.1 Jarrow Formulas Company Information
- 8.7.2 Jarrow Formulas Business Overview
- 8.7.3 Jarrow Formulas Sulforaphane Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Jarrow Formulas Sulforaphane Capsule Product Portfolio
- 8.7.5 Jarrow Formulas Recent Developments
- 8.8 Matakana
- 8.8.1 Matakana Company Information
- 8.8.2 Matakana Business Overview
- 8.8.3 Matakana Sulforaphane Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Matakana Sulforaphane Capsule Product Portfolio
- 8.8.5 Matakana Recent Developments
- 8.9 MCS Formulas
- 8.9.1 MCS Formulas Company Information
- 8.9.2 MCS Formulas Business Overview
- 8.9.3 MCS Formulas Sulforaphane Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 MCS Formulas Sulforaphane Capsule Product Portfolio
- 8.9.5 MCS Formulas Recent Developments
- 8.10 Metagenics
- 8.10.1 Metagenics Company Information
- 8.10.2 Metagenics Business Overview
- 8.10.3 Metagenics Sulforaphane Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Metagenics Sulforaphane Capsule Product Portfolio
- 8.10.5 Metagenics Recent Developments
- 8.11 SMNutrition
- 8.11.1 SMNutrition Company Information
- 8.11.2 SMNutrition Business Overview
- 8.11.3 SMNutrition Sulforaphane Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 SMNutrition Sulforaphane Capsule Product Portfolio
- 8.11.5 SMNutrition Recent Developments
- 8.12 Swanson
- 8.12.1 Swanson Company Information
- 8.12.2 Swanson Business Overview
- 8.12.3 Swanson Sulforaphane Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Swanson Sulforaphane Capsule Product Portfolio
- 8.12.5 Swanson Recent Developments
- 8.13 Throne
- 8.13.1 Throne Company Information
- 8.13.2 Throne Business Overview
- 8.13.3 Throne Sulforaphane Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Throne Sulforaphane Capsule Product Portfolio
- 8.13.5 Throne Recent Developments
- 8.14 Zein
- 8.14.1 Zein Company Information
- 8.14.2 Zein Business Overview
- 8.14.3 Zein Sulforaphane Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Zein Sulforaphane Capsule Product Portfolio
- 8.14.5 Zein Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Sulforaphane Capsule Value Chain Analysis
- 9.1.1 Sulforaphane Capsule Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Sulforaphane Capsule Production Mode & Process
- 9.2 Sulforaphane Capsule Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sulforaphane Capsule Distributors
- 9.2.3 Sulforaphane Capsule Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst